Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
Daniel Ahn's Talks
Daniel Ahn
Mayo Clinic Arizona
FDA approval of pembrolizumab from KN671
October 17, 2023
Daniel Ahn
Mayo Clinic Arizona
KEYNOTE 671 meets OS co-primary endpoint
October 10, 2023
Share
KEYNOTE 671 meets OS co-primary endpoint
https://www.medspoke.co/channel_playlist?object_id=686&tap_id=7208
Copy Link
Email
X
Bluesky
WhatsApp
Linkedin
Facebook
Reddit
Daniel Ahn
Mayo Clinic Arizona
MRD testing in ESCC
October 1, 2023
Why are you reporting this TALK?
